# E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)

Page: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild
Text version: https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild.md
Podcast: [The Evidence Based Rheumatology Podcast](https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175)
Published: 2025-11-12T18:07:48+00:00
Episode link: https://msputman.podbean.com/e/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild/
Audio file: https://mcdn.podbean.com/mf/web/mrj3wqag58vv2vti/e128.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild
Duration seconds: 1143

## Resource

Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out! Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.